Litcius/Paper detail

Cardioprotective effect of pioglitazone and curcumin against diabetic cardiomyopathy in type 1 diabetes mellitus: impact on CaMKII/NF-κB/TGF-β1 and PPAR-γ signaling pathway

Aya A. Gbr, Nayira A. Abdel Baky, Eman A. Mohamed, Heba S. Zaky

2020Naunyn-Schmiedeberg s Archives of Pharmacology50 citationsDOI

Topics & Concepts

PioglitazoneDiabetic cardiomyopathyStreptozotocinMedicineInternal medicineEndocrinologyPeroxisome proliferator-activated receptorDiabetes mellitusOxidative stressCurcuminPharmacologyReceptorType 2 diabetesCardiomyopathyHeart failureCardiovascular Function and Risk FactorsCurcumin's Biomedical ApplicationsPeroxisome Proliferator-Activated Receptors
Cardioprotective effect of pioglitazone and curcumin against diabetic cardiomyopathy in type 1 diabetes mellitus: impact on CaMKII/NF-κB/TGF-β1 and PPAR-γ signaling pathway | Litcius